Rajab Idriss

Rajab Idriss practices at University of South Alabama Burn Center - HOPD in Mobile, Alabama.

Rajab Idriss' NPI, 1184112856, was assigned on April 27, 2018. Rajab Idriss holds Alabama license L.5314SP.

Rajab Idriss' primary practice is University of South Alabama Burn Center - HOPD, at 2451 University Hospital Drive, Mobile, AL 36617.

Rajab Idriss' primary practice is University of South Alabama Burn Center - HOPD in Mobile, Alabama. Rajab Idriss is also affiliated with USA Health University Hospital. The medical group on file is USA Health Physician Billing. Dmand AI also links Rajab Idriss to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rajab Idriss practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Rajab Idriss' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Rajab Idriss' licenses on file in 2 states: Alabama and Massachusetts.

CMS data shows 392 Medicare services from Rajab Idriss across 11 procedure codes in 2024, for 210 Medicare patients. Medicare paid $23,496 for them.

CMS counts 210 Medicare patients who saw Rajab Idriss in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rajab Idriss' median patient age at 67, with 54% women.

In 2024, Rajab Idriss wrote 884 Medicare Part D claims for 188 patients. 81% of them were for generic drugs. CMS names the drug for 732 of them, across 22 drugs with 11 or more claims each, at $757,910 in total drug cost. In 2023, CMS named 628 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Rajab Idriss for performance year 2024, reported as part of a group. Rajab Idriss accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 69 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Rajab Idriss, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Rajab Idriss, published from 2018 to 2021. The most frequent topics are Liver Cirrhosis and Non-alcoholic Fatty Liver Disease. Rajab Idriss' most frequent co-authors are Michael P. Curry, MD, Jamil Sami Alsahhar, MD and Sumeet K. Asrani, MD.

CMS Open Payments shows 110 general payments to Rajab Idriss from 25 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $483.